Geographic Distribution of Triple-Negative Breast Cancer Clinical Trials
Geographic Distribution of Triple-Negative Breast Cancer Clinical Trials The ASCO Post
Geographic Distribution of Triple-Negative Breast Cancer Clinical Trials The ASCO Post
The Molecular Watchman Why Measurable Residual Disease Testing Is Redefining Treatment and Surveillance in Colorectal and Bladder Cancers The ASCO Post
Perlmutter Cancer Center Taps Vivek Subbiah, MD, to Lead Early-Phase Drug Development and Rare Cancer Programs NYU Langone Health
Total ultra-processed food intake not associated with colorectal cancer incidence in large US study Oncology Central
Онколог оценил перспективу исцеления Лерчек от рака NEWS.ru
Metastasis-Directed Ablation Does Not Improve Survival Outcomes in Oligometastatic Breast Cancer The ASCO Post
Жителям Чехова напомнили о профилактике онкологических заболеваний Администрация муниципального округа Чехов Московской области
Жителям Чехова напомнили о профилактике онкологических заболеваний Администрация муниципального округа Чехов Московской области
Scientists at the University of Pittsburgh uncovered the unstable immune cells that can cause up to 40% of immunotherapy patients to experience serious side effects and showed that diet and microbiome composition influence the side effect's severity.
Beginning survivorship care for head and neck cancer patients earlier is linked to better survival and lower recurrence, according to a new University of Pittsburgh study published in JAMA Otolaryngology–Head & Neck Surgery.
Miguel Bronchud: Is There an Urgent Need to Review Cancer Research Investment Priorities? Oncodaily
Блогеру Лерчек стало хуже из-за рецидива рака желудка Рамблер
У Лерчек рецидив онкологии — рак желудка снова прогрессирует, метастазы распространились по всему телу. ВКонтакте
Atezolizumab Plus SBRT in High-Risk, Early-Stage NSCLC: Research Recap Oncology News Central